Erba'daki en son gelişmelerden haberdar olun
“In 2022 we have a renewed focused on innovation for making high medical value diagnostic tests accessible and affordable for all” - Suresh Vazirani
Coverage : Press Release
Medgate Today, January 2022: Q1. Your key innovative business approach which has been helping y
Read More
Transasia ranked as one of the Top 500 companies of India
Medgate Today, January 2022: Indias largest IVD Co., Transasia Bio-Medicals has been ranked as
Increasing footprints through new installations globally
Biospectrum, January 2022: As we step into 2022, we pledge to offer newer and better technologies
Cover story: 2021 saw many initiatives taken by the APAC region to strengthen their capacities for effective preparedness and for the prevention of new and existing infectious diseases.
Biospectrum, December 2021: Launched Indias first high sensitivity Hep C kit Transasia further
Transasia wins Economic Times Healthcare Award 2021 for its COVID-19 testing solutions
Right at the start of the pandemic, the RD teams in India, UK and USA collaborated to fast-track
ErbaLisa HCV Gen 4 Ag+Ab from Transasia Bio-Medicals Ltd.
Hepatitis C Virus (HCV), causes acute and chronic liver inflammation, sometimes leading to permane
Medgate Today - Timely and targeted diagnosis holds the key to developing disease prevention programs and providing optimal treatment
Medgate Today, December 2021: Timely and targeted diagnosis holds the key to developing disease pr
Congratulations, Dr. Ravi Kannan!
Dr. Ravi Kannan of Cachar Cancer Hospital Awarded Padma Shri Dr Ravi Kannan, a renowned oncolog
Transasia Bio-Medicals’ success story features in Fortune India's 11th Anniversary Special issue
Fortune India, October 5, 2021: From a Rs 250 start-up to a Rs. 1,000+ cr turnover with a global p
Medical Buyer, Sep 2021: Advancements in molecular testing
Medical Buyer, Sep 2021:Molecular diagnostics (MDx) is witnessing a fast-paced growth for detectio